Ark Therapeutics Group plc
 
Latest News
EG011 demonstrates ability to grow new blood vessels and restore heart function following heart attack
18 June 2008
spacer
Ark receives SPA from FDA for pivotal Trinam trial
02 June 2008
spacer
Ark Commences Vitor Pilot Phase III Clinical Programme
30 May 2008
spacer
Significant advances with preclinical EG013 and EG014
19 May 2008
spacer
Read more news stories here
Investor relations
2007 Annual Report published.
20 March 2008
spacer
2007 Interim Report published.
04 September 2007
spacer
Visit the Investor Relations section of the web site.
Share Price
55.75 p
Change: 0.50p
Last Trade: 5/7/2008 02:25
View share price data
spacer
Search Site
Use the search form below to search our site.
spacer
Annual Report
Download the latest Annual Report & Accounts
PDF Format
[1.7MB]
Annual Report
spacer
Keep up-to-date
Keep up-to-date with product developments, investor relations information and news with our email updates. Register here to receive our email alerts.
spacer